Search the Newsreel

Syntec Optics (NASDAQ: OPTX) Secures New Space Order, Expanding Footprint from Orbital Highway to Critical Orbital Safety

Syntec Optics (NASDAQ: OPTX) announced a new production order for space optics, focusing on advanced collision avoidance in low Earth orbit. The company will build complete optics to help satellites detect and dodge space debris, addressing the critical issue of space safety amidst a …

Is Yangtze Optical Fibre And Cable Limited (SEHK:6869) Fully Valued On Its Board Reshuffle?

Shanghai Conant Optical Co. Ltd. Class H Revenue Breakdown – HKEX:2276

Option Care Health (NASDAQ:OPCH) Upgraded to "Buy" at Wall Street Zen

Option Care Health (NASDAQ:OPCH) was upgraded to a "Buy" rating from "Hold" by Wall Street Zen. The company recently reported strong quarterly earnings, beating estimates with $1.44 billion in revenue and $0.45 EPS. Despite this upgrade, the broader analyst consensus remains a "Hold" with …

OPCH Q2 Deep Dive: Execution on Acute and Chronic Portfolios Drives Outperformance

OPCH Q2 Deep Dive: Execution on Acute and Chronic Portfolios Drives Outperformance Alternate site health provider Option Care Health (NASDAQ:OPCH) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 1.9% year on year to $1.44 billion. The company expects the …

Optimizerx Stock Price Forecast. Should You Buy OPRX?

StockInvest.us has upgraded OptimizeRx Corporation (OPRX) to a "Buy Candidate" with a technical score of 2.73, up from a "Hold." The stock price increased by 8.26% on the last trading day, reaching $6.55, and is forecasted to rise 16.87% over the next three months. …

Renaissance Technologies LLC Purchases 75,100 Shares of Option Care Health, Inc. $OPCH

Renaissance Technologies LLC increased its stake in Option Care Health (NASDAQ:OPCH) by 15.5%, acquiring an additional 75,100 shares, bringing its total to 558,926 shares valued at $15 million. Institutional investors now own 98.05% of the company, while insiders recently purchased 73,264 shares totaling about …

Bank of America Securities Keeps Their Hold Rating on Option Care Health (OPCH)

Bank of America Securities analyst Joanna Gajuk reiterated a Hold rating on Option Care Health (OPCH) with a price target of $25.00, following the company's recent earnings report. Option Care Health reported quarterly revenue of $1.44 billion and a net profit of $53.91 million …

Option Care Health earnings up next as census recovery takes center stage

Option Care Health (OPCH) is set to report its second-quarter results, with investor attention focused on patient census recovery amidst biosimilar drug headwinds and competitive pressures. Analysts expect improved sequential earnings and revenue, but year-over-year revenue growth is anticipated to be flat, leading to …

Option Care Health Inc Earnings Call Shows Cautious Momentum

Option Care Health Inc. (OPCH) reported its Q2 2026 earnings, showcasing cautious momentum with solid sequential revenue and EBITDA gains, strong cash generation, and an active share repurchase program. Despite these positives, the company faces headwinds in its chronic inflammatory disease portfolio, which is …

Precision Optics Corporation, Inc. Revenue Breakdown – NASDAQ:POCI

Precision Optics Corporation, Inc. (NASDAQ: POCI) generated the majority of its revenue from the United States, contributing $19.09 million USD last year and $19.10 million USD the year prior. This data highlights the company's primary market for its revenue streams. The information is provided …

Optical Cable Corp (OCC) Institutional Confidence

The article reports on Optical Cable Corp's (OCC) institutional confidence score, which is 3.00, placing it 36th in the Communications & Networking industry. Institutional shareholding has increased by 7.66% quarter-over-quarter, with James Simons being the largest institutional shareholder despite a slight decrease in his …

OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of OptimizeRx Corp (OPRX) using key financial metrics. As of July 31, 2026, OPRX has a valuation score of 8.04, placing it 219th in the Software & IT Services industry, with a P/E ratio of 16.38. The article notes …

Optics Valley Union Wins Unanimous Shareholder Backing for 2026 Financing Deal

OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for OptimizeRx Corp (OPRX), highlighting its current risk score of 4.19 and its beta of 1.14 against the S&P 500. It details various risk metrics including volatility, maximum drawdown, and Sharpe Ratio over different periods. The assessment suggests …

Optical Cable Corp (OCC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Optical Cable Corp (OCC), detailing its current price momentum score, support and resistance levels, and indicator readings (MACD, RSI, KDJ, etc.) and moving averages. As of July 30, 2026, OCC's price momentum score is 5.08, trading between …

Option Care Health's Q2 Adjusted Earnings, Revenue Rise

Option Care Health (OPCH) reported an increase in its Q2 adjusted earnings, reaching $0.45 per diluted share. Revenue also rose during the quarter. The full details of the article require a premium subscription.

Option Care Health (OPCH) Stock Drops As Cash Strength Meets Chronic Uncertainty

OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of OptimizeRx Corp (OPRX), focusing on its current stock price momentum, support and resistance levels, and various technical indicators and moving averages. It notes that OPRX's current price momentum score is 3.51, and the stock is trading between …

Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $33

Barrington has reiterated its "Buy" rating for Option Care Health (OPCH.US) and increased its price target to $33. This indicates a positive outlook from the analyst firm regarding the company's future performance and stock value.

Precision Optics Corporation Inc (POCI) Institutional Confidence

This article from TradingKey provides an overview of Precision Optics Corporation Inc (POCI)'s institutional confidence, detailing the score and recent changes. It lists major institutional shareholders and their shareholdings, along with percentage changes in their positions. The data is current as of July 30, …

Option Care Health (OPCH) Could Be 27% Undervalued After Q2 Results And Guidance

Option Care Health (OPCH) recently released strong Q2 2026 results and updated guidance, leading to a 7.06% 30-day stock price return. Despite a year-to-date decline of 30.37%, the company is considered undervalued by some analyses, with a fair value estimate of $28.58 against a …

Optima bank S.A. Reports Earnings Results for the Half Year Ended June 30, 2026

Optimi Health Corp. (OPTH)

Optimi Health Corp. (OPTH) Cash From Operations (Quarterly)

Deutsche Bank Downgrades Option Care Health to Hold From Buy, Adjusts PT to $24 From $26

Deutsche Bank has downgraded Option Care Health (OPCH) from a "Buy" rating to "Hold" and reduced its price target from $26 to $24. This action indicates a revised outlook on the stock's performance. Previously, Stephens also downgraded Option Care to "Equal Weight" from "Overweight" …

Huachuang Securities Remains a Buy on Shanghai Conant Optical Co. Ltd. Class H (2276)

Optima bank S.A. 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:OPMBF) 2026-07-30

Deutsche Bank cuts Option Care Health stock rating on growth concerns

Deutsche Bank downgraded Option Care Health (NASDAQ:OPCH) from Buy to Hold, lowering its price target to $24.00 from $26.00 due to concerns about the company's long-term growth prospects. Despite an EBITDA beat, the firm noted challenges in maintaining acute growth significantly above market and …

Option Care: Q2 Earnings Snapshot

This article provides a brief earnings snapshot for Option Care's Q2 performance. As a content cleaning and metadata extraction exercise, the article itself contains no financial details or specific figures beyond its title. It's an example of an article placeholder or a very short, …

GUIDANCE: (OPCH) Option Care Health Expects Full Year 2026 Revenue Range $5.68B - $5.78B, Vs. FactSet Est of $5.71B

Option Care Health (OPCH) announced its financial guidance for the full year 2026, expecting revenue to be in the range of $5.68 billion to $5.78 billion. This guidance compares to FactSet's estimated revenue of $5.71 billion for the same period.

Ensign Group, Humana, Vitas Healthcare, Option Care Health report second-quarter earnings

The Ensign Group, Humana, Vitas Healthcare, and Option Care Health recently reported their second-quarter earnings. Ensign Group saw strong demand and anticipates a busy acquisition period, planning to expand into new states and having acquired 71 assets since 2025. Humana reaffirmed its commitment to …

BlackRock (OPRX) discloses 342,250 OptimizeRx shares held with sole voting power

BlackRock, Inc. has filed an amendment (Schedule 13G/A) disclosing its beneficial ownership in OptimizeRx Corp (OPRX). As of June 30, 2026, BlackRock's reporting business units beneficially owned 342,250 shares of OptimizeRx common stock, representing 1.8% of the class. BlackRock reports having sole voting and …

Option Care Health Q2 Earnings Rise; Provides Q3 View; Reaffirms FY26 Revenue Outlook; Stock Up

(RTTNews) - Option Care Health, Inc. (OPCH) announced financial results for the second quarter ended on June 30, 2026, reflecting improved earnings. In addition, the company provided third-quarter guidance and reaffirmed its outlook for full-year 2026. Following the news, OPCH is up over 6%. …

Option Care Health (NASDAQ:OPCH) Shares Gap Up on Earnings Beat

Option Care Health Releases Q2 2026 Financial Results

Option Care Health (OPCH) exceeded Wall Street expectations for the first half of 2026, reporting adjusted earnings per share of $0.45 and revenue of $1.44 billion. The company, a leading home infusion therapy provider, projects full-year 2026 adjusted EPS between $1.85 and $1.92, with …